Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-22-010256
Filing Date
2022-04-29
Accepted
2022-04-29 16:16:24
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A wint20220331_10ka.htm   iXBRL 10-K/A 478390
2 EXHIBIT 31.3 ex_364521.htm EX-31.3 4883
3 EXHIBIT 31.4 ex_364522.htm EX-31.4 4648
4 EXHIBIT 32.2 ex_364523.htm EX-32.2 6492
  Complete submission text file 0001437749-22-010256.txt   756084

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20211231.xsd EX-101.SCH 3601
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20211231_def.xml EX-101.DEF 17163
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20211231_lab.xml EX-101.LAB 23278
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20211231_pre.xml EX-101.PRE 18144
10 EXTRACTED XBRL INSTANCE DOCUMENT wint20220331_10ka_htm.xml XML 6570
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39290 | Film No.: 22875671
SIC: 2836 Biological Products, (No Diagnostic Substances)